Fig. 3From: Cost-effectiveness of 82-Rubidium PET myocardial perfusion imaging for the diagnosis of myocardial ischemia depending on the prevalence of coronary artery diseaseCost-effectiveness plane: Incremental Cost-Effectiveness Ratio of Costs per additional accurate diagnosis at 12 months in each subgroupBack to article page